Literature DB >> 24688763

The influence of virus infections on the course of COPD.

H Frickmann, S Jungblut, T O Hirche, U Groß, M Kuhns, A E Zautner.   

Abstract

Chronic obstructive pulmonary disease (COPD) is extensively influenced by viral infections. The mechanisms of how viral agents affect the pathogenesis and prognosis of COPD are numerous. In general, patients with infectious exacerbations are characterized by longer hospitalization periods and greater impairment of several lung function parameters than those with non-infectious exacerbations. Prodromal, clinical, and outcome parameters fail to distinguish virally from non-virally induced illnesses in cases of exacerbations. The importance of infections with respiratory and non-respiratory viral agents for pathogenesis and course of COPD is detailed. Human adenovirus, non-respiratory viruses including human immunodeficiency virus, human metapneumovirus, influenza virus, human rhinovirus, and respiratory syncytial virus are especially stressed.

Entities:  

Keywords:  COPD; chronic obstructive pulmonary disease; human adenovirus; human metapneumovirus; human rhinovirus; infection; influenza virus; respiratory syncytial virus; virus

Year:  2012        PMID: 24688763      PMCID: PMC3962752          DOI: 10.1556/EuJMI.2.2012.3.2

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  109 in total

Review 1.  [Viral infection in acute exacerbation of COPD].

Authors:  Omar Kherad; Pierre-Olivier Bridevaux; Laurent Kaiser; Jean-Paul Janssens; Olivier Rutschmann
Journal:  Rev Med Suisse       Date:  2011-11-16

Review 2.  Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease.

Authors:  Michael J Holtzman; Jeffrey W Tyner; Edy Y Kim; Mindy S Lo; Anand C Patel; Laurie P Shornick; Eugene Agapov; Yong Zhang
Journal:  Proc Am Thorac Soc       Date:  2005

Review 3.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

Review 4.  Childhood viral infection and the pathogenesis of asthma and chronic obstructive lung disease.

Authors:  J C Hogg
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

Review 5.  Respiratory syncytial virus infection in adults.

Authors:  Yoshihiko Murata
Journal:  Curr Opin Pulm Med       Date:  2008-05       Impact factor: 3.155

6.  Inflammatory response in acute viral exacerbations of COPD.

Authors:  G Rohde; I Borg; A Wiethege; M Kauth; S Jerzinowski; T An Duong Dinh; T T Bauer; A Bufe; G Schultze-Werninghaus
Journal:  Infection       Date:  2008-09-15       Impact factor: 3.553

Review 7.  A human rhinovirus model of chronic obstructive pulmonary disease exacerbations.

Authors:  Marco Contoli; Gaetano Caramori; Patrick Mallia; Alberto Papi; Sebastian L Johnston
Journal:  Contrib Microbiol       Date:  2007

8.  Relevance of human metapneumovirus in exacerbations of COPD.

Authors:  G Rohde; I Borg; U Arinir; J Kronsbein; R Rausse; T T Bauer; A Bufe; G Schultze-Werninghaus
Journal:  Respir Res       Date:  2005-12-21

9.  Respiratory viral infections in patients with chronic, obstructive pulmonary disease.

Authors:  J David Beckham; Ana Cadena; Jiejian Lin; Pedro A Piedra; W Paul Glezen; Stephen B Greenberg; Robert L Atmar
Journal:  J Infect       Date:  2005-05       Impact factor: 6.072

Review 10.  Rhinovirus and the lower respiratory tract.

Authors:  Frederick G Hayden
Journal:  Rev Med Virol       Date:  2004 Jan-Feb       Impact factor: 6.989

View more
  10 in total

1.  Distinct Chronic Post-Viral Lung Diseases upon Infection with Influenza or Parainfluenza Viruses Differentially Impact Superinfection Outcome.

Authors:  Geyon L Garcia; Alex Valenzuela; Tomaz Manzoni; Andrew E Vaughan; Carolina B López
Journal:  Am J Pathol       Date:  2019-12-19       Impact factor: 4.307

2.  Influence of thromboembolic events in the prognosis of COVID-19 hospitalized patients. Results from a cross sectional study.

Authors:  Francisco Purroy; Gloria Arqué
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

3.  Viral Etiology of Chronic Obstructive Pulmonary Disease Exacerbations during the A/H1N1pdm09 Pandemic and Postpandemic Period.

Authors:  Ivan Sanz; Sonia Tamames; Silvia Rojo; Mar Justel; José Eugenio Lozano; Carlos Disdier; Tomás Vega; Raúl Ortiz de Lejarazu
Journal:  Adv Virol       Date:  2015-05-07

Review 4.  More Pathogenicity or Just More Pathogens?-On the Interpretation Problem of Multiple Pathogen Detections with Diagnostic Multiplex Assays.

Authors:  Andreas E Zautner; Uwe Groß; Matthias F Emele; Ralf M Hagen; Hagen Frickmann
Journal:  Front Microbiol       Date:  2017-06-29       Impact factor: 5.640

5.  Analysis of the polarization states of the alveolar macrophages in chronic obstructive pulmonary disease samples based on miRNA-mRNA network signatures.

Authors:  Wen Shen; Shukun Wang; Ruili Wang; Yang Zhang; Hong Tian; Xiaolei Yang; Wei Wei
Journal:  Ann Transl Med       Date:  2021-08

6.  The need for vaccination in adults with chronic (noncommunicable) diseases in India - lessons from around the world.

Authors:  Agam Vora; Alberta Di Pasquale; Shafi Kolhapure; Ashish Agrawal; Someya Agrawal
Journal:  Hum Vaccin Immunother       Date:  2022-04-13       Impact factor: 4.526

7.  The Influence of Influenza Virus Infections in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Kuang-Ming Liao; Yi-Ju Chen; Chuan-Wei Shen; Shao-Kai Ou; Chung-Yu Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-09-14

8.  Interplay between hypoxia and inflammation contributes to the progression and severity of respiratory viral diseases.

Authors:  Sulagna Bhattacharya; Sakshi Agarwal; Nishith M Shrimali; Prasenjit Guchhait
Journal:  Mol Aspects Med       Date:  2021-07-19

Review 9.  Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation.

Authors:  Hong Guo-Parke; Dermot Linden; Sinéad Weldon; Joseph C Kidney; Clifford C Taggart
Journal:  Front Immunol       Date:  2020-06-16       Impact factor: 7.561

Review 10.  COVID-19 Susceptibility in chronic obstructive pulmonary disease.

Authors:  Jordi Olloquequi
Journal:  Eur J Clin Invest       Date:  2020-09-02       Impact factor: 5.722

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.